# US 2025/0084052 A1 · 3-(2-(4-methoxypyridin-3-yl)-4,5-diphenyl-1h-imidazol-1-yl)-n,n-dimethylpropan-1-amine as an anti-cancer compound

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0084052 A1
- Document ID: US20250084052A1
- Status: Published application
- Kind: A1
- Application number: 18/394,703
- Filed: 2023-12-22
- Published: 2025-03-13
- Earliest claimed: 2023-09-12
- Assignees: King Faisal University
- Applicants: King Faisal University
- Inventors: HANY MOHAMED ABD EL-LATEEF AHMED; MAI MOSTAFA KHALAF ALI; ANTAR AHMED ABDELHAMID AHMED; ADEL A. MARZOUK
- Web page: https://patentgrep.com/patent/US20250084052A1

## CPC

- C07D 401/04: directly linked by a ring-member-to-ring-member bond
- A61P 35/00: Antineoplastic agents
- C07D 401/14: containing three or more hetero rings
- C07B 2200/13: Crystalline forms, e.g. polymorphs
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

A 3-(2-(4-methoxypyridin-3-yl)-4,5-diphenyl-1H-imidazol-1-yl)-N,N-dimethylpropan-1-amine compound, its synthesis, and its use as an anticancer agent.

## Claims

### Claim at position 1

-4. (canceled)

### Claim 5

A method of treating cancer in a patient comprising administering to a patient in need thereof a therapeutically effective amount of a 3-(2-(4-methoxypyridin-3-yl)-4,5-diphenyl-1H-imidazol-1-yl)-N,N-dimethylpropan-1-amine compound having the formula I:
wherein the cancer is selected from the group consisting of prostate cancer and osteosarcoma.

### Claim at position 3

-14. (canceled)
